Overview of Isoniazid

Client Email Product
Prestwick3_000161
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

  • WHO-GMP
Applications: SuperTab® 11SD offers the best compactability of all grades of lactose, and it is well suited to direct compression applications. Due to the low moisture content, it is used in the formulations containing moisture sensitive drugs.
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Ph. Eur., Lactose monograph / USP-NF, JP Anhydrous lactose monograph
Technical Specifications: Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle size- D10-15 ?m, D50- 170 ?m, D90- 340 ?m; Hausner ratio-1,25
  • FDA
  • EDQM
Applications: Advantose® FS95 spray-dried fructose is coprocessed with a small quantity of starch, which results in a highly compressible excipient for pharmaceutical, nutraceutical, and chewable vitamin applications.
Ingredient(s): Fructose
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.
Dosage Form: Tablet
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP
Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42
  • FDA
  • EDQM
Applications: For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Ingredient(s): Lauryl Sulfate
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Compressol® SM polyol drug delivery system is a directly compressible platform consisting of mannitol and sorbitol. It assists the formulator with high active-loading formulations and difficult-to-compress actives.
Ingredient(s): Mannitol
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories
Ingredient(s): Stearic Acid
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Ready-to-use direct compression solution for tablets.
Ingredient(s): Crospovidone
Dosage Form: Tablet, Granule / Pellet
More Info on Category: Granulation, Direct Compression
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Ingredient(s): Povidone
Dosage Form: Tablet, Granule / Pellet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P
Technical Specifications: Not Available
  • EDQM
Applications: Capsule Filling, Direct Compression, Binding, Disintegration
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: EXCiPACT
  • TABLET;ORAL - 50MG;300MG;120MG
  • TABLET;ORAL - 100MG
  • TABLET;ORAL - 300MG
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us